A-366 is a potent and selective G9a/GLP histone lysine methyltransferase inhibitor (IC₅₀ = 3.3 nM). It displays >1000-fold selectivi ty for G9a/GLP over 21 other methyltransferases. A-366 has been shown to inhibit H3K9 methylation in prostate cancer

Numéro d'article : BIOV2859-1
Unité de mesure : 1 MG
https://grogg-prod.braintec.cloud/web/image/product.template/923588/image_1920?unique=7d71d66

133.00 CHF 133.0 CHF 133.00 CHF

133.00 CHF

Not Available For Sale

    Cette combinaison n'existe pas.

    Délai de livraison actuel sur demande

    Fabricant : BIOVISION
    Numéro du fabricant : 2859-1
    Température de stockage : Freezer (-20)

    A-366 is a potent and selective G9a/GLP histone lysine methyltransferase inhibitor (IC₅₀ = 3.3 nM). It displays >1000-fold selectivi ty for G9a/GLP over 21 other methyltransferases. A-366 has been shown to inhibit H3K9 methylation in prostate cancer